CynthiaBecherStroutMD

Family Medicine • Mount Pleasant, SC

Full-Time Research Investigator, Coastal Carolina Research Center

Join to view full profile

Are you Dr. Strout?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 13 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
1156 Bowman Rd Unit 102
Mount Pleasant, SC 29464
Phone+1 843-856-3784

Fax+1 843-856-3788
Is this information wrong?

Summary

Dr. Cynthia Strout, MD is a family physician in Mount Pleasant, South Carolina. She is currently licensed to practice medicine in South Carolina. She is a Full-Time Research Investigator at Coastal Carolina Research Center.

Education & Training

Indiana University School of MedicineClass of 1985

Certifications & Licensure

SC State Medical License 1993 - 2025

Clinical Trials

YM443 in Subjects With Functional Dyspepsia Start of enrollment: 2004 Mar 10
Completed
Phase 2
Safety, Pharmacokinetics, and Efficacy Study of NB-001 to Treat Recurrent Herpes Labialis Start of enrollment: 2007 Feb 01
Completed
Phase 2
Study of Atorvastatin/Fenofibrate (LCP-AtorFen) Combination Therapy in Dyslipidemia Start of enrollment: 2007 Jul 01
Completed
Phase 2
12-Month, Open-Label, Extension Study of LCP-AtorFen in Dyslipidemia Start of enrollment: 2007 Oct 01
Completed
Phase 2, Phase 3
24-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms Start of enrollment: 2010 Mar 01
Completed
Phase 3
Safety and Efficacy of Econazole Nitrate Foam 1% in Subjects With Tinea Pedis Start of enrollment: 2011 May 01
Completed
Phase 3
Efficacy/Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS) Start of enrollment: 2011 May 01
Completed
Phase 3
Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism Start of enrollment: 2011 Sep 01
Completed
Phase 3
Assessing the Efficacy, Safety, and Tolerability of Met DR in Subjects With T2DM Over 12 Weeks Start of enrollment: 2013 Apr 01
Completed
Phase 2
Study of DA-9801 to Treat Diabetic Neuropathy Start of enrollment: 2013 Nov 01
Completed
Phase 2
A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache Start of enrollment: 2014 Jul 07
Completed
Phase 2
A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis Start of enrollment: 2015 Aug 01
Completed
Phase 3
Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine Start of enrollment: 2016 Jun 01
Completed
Phase 2, Phase 3
BARDA Securing Anthrax Immunity For the Elderly Start of enrollment: 2018 May 09
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

59 citations
Immunogenicity and safety of Fluzone(®) intradermal and high-dose influenza vaccines in older adults ≥65 years of age: a randomized, controlled, phase II trial.
Peter H. Tsang, Geoffrey J. Gorse, Cynthia Strout, Malcolm Sperling, David P. Greenberg, Ayca Ozol-Godfrey, Carlos A. DiazGranados, Victoria Landolfi> ;Vaccine. 2014 May 1
28 citations
Intradermally-administered influenza virus vaccine is safe and immunogenic in healthy adults 18-64 years of age.
Geoffrey J. Gorse, Ann R. Falsey, John A. Fling, Terry L. Poling, Cynthia Strout, Peter H. Tsang> ;Vaccine. 2013 May 1

Press Mentions

MUSC Participating in COVID-19 Vaccine Clinical Trials for JuvenilesMay 4th, 2021